Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: New Port Richey FL, Port Charlotte FL, Winter Park FL,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
for
Obesity or Overweight
Location: New Port Richey FL, Port Orange FL, Anniston AL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07843498
Phase 3, Recruiting
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
for
Squamous Cell Carcinoma, Head and Neck Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06137274
Phase 2, Recruiting
New
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight,
Location: New Port Richey FL, Oviedo FL, Jacksonville FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07845500
Phase 3, Recruiting
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
for
Endometriosis
Location: Sarasota FL, Norfolk VA, Columbus OH, Seattle WA
Sponsor: Enteris BioPharma Inc.
Sex: Female
Age: 18 - 49
Code: NCT05096065
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
for
Solid Tumors, Sarcomas
Location: Sarasota FL, Fairfax VA, St Louis MO, New York NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07374848
Phase 1, Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Sarasota FL, Nashville TN, Houston TX, Avon IN,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06752681
Phase 1, Recruiting
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: Sarasota FL, Knoxville TN, Chapel Hill NC, Danville PA,
A Study of DS5361b in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Sarasota FL, Fairfax VA, Irving TX, San Antonio TX,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07182591
Phase 1, Recruiting
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
for
Thyroid Carcinoma
Location: Sarasota FL, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07218315
Recruiting
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
for
Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21),
Location: Sarasota FL, Atlanta GA, Baton Rouge LA, Houston TX,
Sponsor: BillionToOne Inc.
Sex: Female
Age: 0+
Code: NCT07643896
Recruiting
Breast Cancer Liquid Biopsy Trial
for
Breast Cancer, Cancer
Location: Sarasota FL, Orlando FL, Ocala FL, Hollywood FL,
Sponsor: Anthony Magliocco
Sex: All
Age: 18+
Code: NCT04962529
Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy